Standard Biotools (LAB) Cash from Operations Growth (3y) (2013 - 2026)
Standard Biotools (LAB) Cash from Operations Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.67 Bn | 194.07 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 129.56 Bn | 126.09 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 119.87 Bn | 110.65 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.80 Bn | 73.27 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 52.66 Bn | 48.41 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.56 Bn | 32.61 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 34.16 Bn | 32.05 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.44 Bn | 23.12 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 9.30% |
| 10 | Standard Biotools | 258.10 Mn | -218.62 Mn | 10.54 Mn | -3.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.39% |
| Mar 31, 2026 | -76.43% |
| Dec 31, 2025 | 60.41% |
| Sep 30, 2025 | 3.38% |
| Jun 30, 2025 | 11.67% |
| Mar 31, 2025 | -24.77% |
| Sep 30, 2024 | 9.06% |
| Jun 30, 2024 | -12.31% |
| Mar 31, 2024 | -69.19% |
| Dec 31, 2023 | -55.59% |
| Sep 30, 2023 | -35.38% |
| Jun 30, 2023 | -49.54% |
| Mar 31, 2023 | -25.48% |
| Dec 31, 2022 | -51.47% |
| Sep 30, 2022 | -75.56% |
| Jun 30, 2022 | -81.53% |
| Mar 31, 2022 | 8.17% |
| Sep 30, 2021 | -108.92% |
| Jun 30, 2021 | -85.43% |
| Mar 31, 2021 | 7.26% |